Amyloid

Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines

Jean D. Sipe, Merrill D. Benson, Joel N. Buxbaum et al. · 2016 · 604 citations

Life Sciences, Biochemistry, Pathology +17

Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee

Merrill D. Benson, Joel N. Buxbaum, David Eisenberg et al. · 2018 · 575 citations · Full text

Life Sciences, Biochemistry, Pathology +13

Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee

Merrill D. Benson, Joel N. Buxbaum, David Eisenberg et al. · 2020 · 407 citations · Full text

Life Sciences, Molecular Biology, Pathology +15

Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial

David Adams, Ivailo Tournev, Mark Taylor et al. · 2022 · 379 citations · Full text

Medicine, Neurology, Pharmacotherapy +13

Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis

Jean D. Sipe, Merrill D. Benson, Joel N. Buxbaum et al. · 2010 · 364 citations

Life Sciences, Biochemistry, Pathology +17